(Q28263773)

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Mutations in CBL occur frequently in juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Viral infections in juvenile myelomonocytic leukemia: prevalence and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Molecular basis of juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

RAS pathway mutations in juvenile myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

The GTPase superfamily: a conserved switch for diverse cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

The neurofibromatosis type 1 gene encodes a protein related to GAP

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Occurrence of myeloproliferative disorder in patients with Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Crystal structure of the tyrosine phosphatase SHP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

The Cbl interactome and its functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Germline KRAS mutations cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

An unexpected new role of mutant Ras: perturbation of human embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

A restricted spectrum of NRAS mutations causes Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Transient abnormal myelopoiesis in Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Targeting RAS signaling pathways in juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631360-000000000-00000

11th Symposium on Aplastic Anemia and 9th Symposium on Myelodysplastic Syndromes in Children

21 January 2018

1 reference

12 December 2020

Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

1 reference

12 December 2020

Differentiating juvenile myelomonocytic leukemia from infectious disease

1 reference

12 December 2020

Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival

1 reference

12 December 2020

Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors

1 reference

12 December 2020

1 reference

12 December 2020

Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations

1 reference

12 December 2020

JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia

1 reference

12 December 2020

[Prognosis of 75 patients with juvenile myelomonocytic leukemia: prospective study by MDS committee in the Japanese Society of Pediatric Hematology].

1 reference

12 December 2020

Mutations of the N-ras gene in juvenile chronic myelogenous leukemia

1 reference

12 December 2020

Mutation analysis of SIPA1 in patients with juvenile myelomonocytic leukemia

1 reference

12 December 2020

Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations

1 reference

12 December 2020

Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.

1 reference

12 December 2020

Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia

1 reference

12 December 2020

Gene Expression–Based Classification As an Independent Predictor of Clinical Outcome in Juvenile Myelomonocytic Leukemia

1 reference

12 December 2020

Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia

1 reference

12 December 2020

Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome

1 reference

12 December 2020